XML 34 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. Segment Information and Concentrations (Details) (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Depreciation and Amortization     $ 88,500 $ 89,000
Benchtop Laboratory Equipment [Member]
       
Revenues 1,154,000 1,164,900 2,223,700 2,229,700
Foreign Sales 823,400 747,900 1,444,200 1,369,600
Income (Loss) from Operations 119,800 157,200 238,100 274,800
Assets 2,787,400 2,485,700 2,787,400 2,485,700
Long-lived Asset Expenditures 10,100 7,100 20,000 9,200
Depreciation and Amortization 11,600 11,500 22,600 22,600
Catalyst Research Instruments [Member]
       
Revenues 463,400 664,900 803,100 949,200
Foreign Sales 88,900 279,800 162,400 519,000
Income (Loss) from Operations 2,100 68,200 (101,900) (66,100)
Assets 1,704,400 1,695,400 1,704,400 1,695,400
Long-lived Asset Expenditures 0 700 0 18,100
Depreciation and Amortization 8,500 9,200 17,600 18,500
Bioprocessing Systems [Member]
       
Revenues 130,400 47,100 157,100 49,700
Foreign Sales 0 0 2,000 0
Income (Loss) from Operations 64,600 (30,900) 47,800 (105,900)
Assets 981,600 963,100 981,600 963,100
Long-lived Asset Expenditures 6,000 0 6,500 0
Depreciation and Amortization 24,200 24,000 48,300 47,900
Corporate and Other [Member]
       
Revenues 0 0 0 0
Foreign Sales 0 0 0 0
Income (Loss) from Operations (10,000) 0 (10,500) 0
Assets 829,800 915,800 829,800 915,800
Long-lived Asset Expenditures 0 0 0 0
Depreciation and Amortization 0 0 0 0
Consolidated [Member]
       
Revenues 1,747,800 1,876,900 3,183,900 3,228,600
Foreign Sales 912,300 1,027,700 1,608,600 1,888,600
Income (Loss) from Operations 176,500 194,500 173,500 102,800
Assets 6,303,200 6,060,000 6,303,200 6,060,000
Long-lived Asset Expenditures 16,100 7,800 26,500 27,300
Depreciation and Amortization $ 44,300 $ 44,700 $ 88,500 $ 89,000